How do I buy Lexaria Bioscience (LEXX) stock?

You can purchase shares of Lexaria Bioscience (NASDAQ:LEXX) through any online brokerage.View our list of the best stock brokerages

Who are Lexaria Bioscience (LEXX) competitors?

Other companies in Lexaria Bioscience’s space includes: Cingulate Inc (NASDAQ:CING), Iterum Therapeutics PLC (NASDAQ:ITRM), Gelteq Ltd (NASDAQ:GELS), Cocrystal Pharma Inc (NASDAQ:COCP) and SCYNEXIS Inc (NASDAQ:SCYX).

What is the forecast, or price target, for Lexaria Bioscience (LEXX) stock?

Lexaria Bioscience has a consensus price target of $6.75.

What is the current price for Lexaria Bioscience (LEXX)?

The stock price for Lexaria Bioscience (NASDAQ: LEXX) is $0.795 last updated January 22, 2026 at 9:27 AM EST.

Does Lexaria Bioscience (LEXX) pay a dividend?

There are no upcoming dividends for Lexaria Bioscience.

When is Lexaria Bioscience (NASDAQ:LEXX) reporting earnings?

Lexaria Bioscience does not have any upcoming earnings scheduled.

Is Lexaria Bioscience (LEXX) going to split?

There is no upcoming split for Lexaria Bioscience.

What sector and industry does Lexaria Bioscience (LEXX) operate in?

Lexaria Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Lexaria Bioscience (LEXX) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Pharmaceuticals

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability...

Comments